Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions

NCT: NCT05464147 · COMPLETED

NCT IDNCT05464147
StatusCOMPLETED
Start Date2021-10-19
Completion2025-08-01
SponsorElixir Medical Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The aim of the DYNAMITE study is to investigate the (a) acute procedural and (b) 9-month follow-up performance of DynamX Drug-Eluting Coronary Bioadaptor System implantation in complex coronary lesions.

Frequently Asked Questions

What is DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions?

DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions is a clinical trial registered under NCT05464147. Current status: COMPLETED.

What is the status of NCT05464147?

The current status of NCT05464147 (DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions) is: COMPLETED.

When did DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions start?

DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions started on 2021-10-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑